Lee Chan Henry
CIK 1980648
Transactions on file
70
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-09-30 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 1,115 | $418.1K | +0.7% | open → |
| 2026-08-14 | 2026-08-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 2,666 | $959.8K | +4.9% | open → |
| 2026-08-14 | 2026-08-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 796 | $126.6K | +137.5% | open → |
| 2026-08-14 | 2026-08-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 1,058 | $225.7K | +77.0% | open → |
| 2026-08-14 | 2026-08-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 812 | $157.9K | +94.2% | open → |
| 2026-08-03 | 2026-07-30 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 1,044 | $337.9K | +16.7% | open → |
| 2026-07-24 | 2026-07-22 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 1,669 | $542.4K | +16.2% | open → |
| 2026-07-24 | 2026-07-22 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 490 | $77.9K | +137.5% | open → |
| 2026-07-24 | 2026-07-22 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 665 | $141.9K | +77.0% | open → |
| 2026-07-24 | 2026-07-22 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 514 | $100.0K | +94.2% | open → |
| 2026-07-10 | 2026-07-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 664 | $200.8K | +24.9% | open → |
| 2026-07-10 | 2026-07-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 196 | $31.2K | +137.5% | open → |
| 2026-07-10 | 2026-07-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 266 | $56.7K | +77.0% | open → |
| 2026-07-10 | 2026-07-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 202 | $39.3K | +94.2% | open → |
| 2026-06-18 | 2026-06-16 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 590 | $156.9K | +42.0% | open → |
| 2026-06-15 | 2026-06-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 428 | $110.3K | +46.6% | open → |
| 2026-06-15 | 2026-06-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Grant | 45,071 | $0.00 | — | open → |
| 2026-06-10 | 2026-06-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 160 | $43.4K | +39.2% | open → |
| 2026-06-10 | 2026-06-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 711 | $192.1K | +39.7% | open → |
| 2026-05-15 | 2026-05-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 332 | $103.2K | +21.5% | open → |
| 2026-05-15 | 2026-05-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 98 | $15.6K | +137.5% | open → |
| 2026-05-15 | 2026-05-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 133 | $28.4K | +77.0% | open → |
| 2026-05-15 | 2026-05-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 101 | $19.6K | +94.2% | open → |
| 2026-04-10 | 2026-04-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 332 | $103.4K | +21.2% | open → |
| 2026-04-10 | 2026-04-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 98 | $15.6K | +137.5% | open → |
| 2026-04-10 | 2026-04-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 133 | $28.4K | +77.0% | open → |
| 2026-04-10 | 2026-04-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 101 | $19.6K | +94.2% | open → |
| 2025-02-25 | 2025-02-21 | BGNE BeiGene, Ltd. | Officer SVP, General Counsel | Sale | 100 | $26.0K | — | open → |
| 2025-02-25 | 2025-02-21 | BGNE BeiGene, Ltd. | Officer SVP, General Counsel | Sale | 598 | $154.7K | — | open → |
| 2025-02-25 | 2025-02-21 | BGNE BeiGene, Ltd. | Officer SVP, General Counsel | Sale | 504 | $129.4K | — | open → |
| 2025-03-03 | 2025-02-27 | BGNE BeiGene, Ltd. | Officer SVP, General Counsel | Sale | 1,205 | $331.4K | — | open → |
| 2025-03-07 | 2025-03-05 | BGNE BeiGene, Ltd. | Officer SVP, General Counsel | Grant | 40,209 | $0.00 | — | open → |
| 2025-06-10 | 2025-06-06 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 230 | $59.1K | +47.1% | open → |
| 2025-06-10 | 2025-06-06 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 470 | $120.2K | +47.6% | open → |
| 2025-06-12 | 2025-06-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Grant | 46,878 | $0.00 | — | open → |
| 2025-06-18 | 2025-06-16 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 422 | $112.5K | +41.7% | open → |
| 2025-12-12 | 2025-12-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 332 | $107.9K | +16.2% | open → |
| 2025-12-12 | 2025-12-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 98 | $15.6K | +137.5% | open → |
| 2025-12-12 | 2025-12-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 133 | $28.4K | +77.0% | open → |
| 2025-12-12 | 2025-12-11 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 101 | $19.6K | +94.2% | open → |
| 2025-12-12 | 2025-12-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 332 | $105.7K | +18.6% | open → |
| 2025-12-12 | 2025-12-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 98 | $15.6K | +137.5% | open → |
| 2025-12-12 | 2025-12-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 133 | $28.4K | +77.0% | open → |
| 2025-12-12 | 2025-12-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 101 | $19.6K | +94.2% | open → |
| 2025-11-14 | 2025-11-12 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 332 | $116.2K | +7.9% | open → |
| 2025-11-14 | 2025-11-12 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 664 | $231.6K | +8.3% | open → |
| 2025-11-14 | 2025-11-12 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 296 | $47.1K | +137.5% | open → |
| 2025-11-14 | 2025-11-12 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 398 | $84.9K | +77.0% | open → |
| 2025-11-14 | 2025-11-12 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 302 | $58.7K | +94.2% | open → |
| 2025-10-10 | 2025-10-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 4,162 | $1.46M | +7.5% | open → |
| 2025-10-10 | 2025-10-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 4,733 | $1.66M | +7.8% | open → |
| 2025-10-10 | 2025-10-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 664 | $231.0K | +8.6% | open → |
| 2025-10-10 | 2025-10-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 296 | $47.1K | +137.5% | open → |
| 2025-10-10 | 2025-10-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 8,961 | $1.91M | +77.0% | open → |
| 2025-10-10 | 2025-10-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 302 | $58.7K | +94.2% | open → |
| 2025-10-10 | 2025-10-08 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 1,112 | $389.2K | +7.9% | open → |
| 2025-07-31 | 2025-07-30 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 920 | $280.2K | +24.0% | open → |
| 2025-08-15 | 2025-08-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 3,849 | $1.16M | +25.5% | open → |
| 2025-08-15 | 2025-08-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 6,052 | $1.82M | +25.8% | open → |
| 2025-08-15 | 2025-08-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 3,849 | $612.1K | +137.5% | open → |
| 2025-08-15 | 2025-08-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 1,112 | $333.6K | +25.9% | open → |
| 2025-08-15 | 2025-08-13 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 4,381 | $852.0K | +94.2% | open → |
| 2025-09-12 | 2025-09-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 300 | $98.0K | +15.6% | open → |
| 2025-09-12 | 2025-09-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 4,776 | $1.55M | +16.1% | open → |
| 2025-09-12 | 2025-09-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 3,318 | $1.08M | +15.9% | open → |
| 2025-09-12 | 2025-09-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 1,796 | $383.1K | +77.0% | open → |
| 2025-09-12 | 2025-09-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 6,802 | $1.32M | +94.2% | open → |
| 2025-09-12 | 2025-09-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 1,112 | $361.4K | +16.2% | open → |
| 2025-09-12 | 2025-09-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Sale | 500 | $164.0K | +15.2% | open → |
| 2025-09-12 | 2025-09-10 | ONC BeOne Medicines Ltd. | Officer SVP, General Counsel | Exer. | 296 | $47.1K | +137.5% | open → |
